The SPAC said merger partner Clever Leaves, a multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, has entered into a $4 million commercial agreement with pharmaceutical company GreenCare to license and distribute certain Clever Leaves’ white label cannabis-derived products. Manufacturing will occur in Clever Leaves’ facilities in Colombia. An initial payment of $2 million has already been made, the companies said. Read more.
Related Posts
L Catterton Asia Prices $250M IPO
L Catterton intends to focus on high-growth, consumer technology sectors across Asia.
Alset Capital Acquisition Aims to Tack on 3 More Months While Trying to Close HWH Int’l Deal
Terms of the already-approved deal call for Alset to issue $125 million in stock to the combined company. The closing conditions have not been met.
Tiga Closes IPO With Full Exercise of Underwriters’ Option
The SPAC said its total raise was $276 million.
HNR Acquisition Amends Stock Purchase Agreement with White Lion Covering 440,000 Shares
While a purchase notice is active, the SPAC may issue a rapid purchase notice to White Lion to close on the rapid purchase within two business days.